Our findings highlight a critical role for CBD in reducing NRF-2 expression, which in turn enhances the production of cellular ROS, providing a novel insight to the role of CBD in overcoming this pro-apoptotic pathway in CR NSCLC. The gene discussed is NFE2L2; the disease is non-small cell lung carcinoma.